Unicorns Podcast: Medicinal cannabis market lights up with Cymra Life Sciences
Link copied to
The Unicorns Podcast connects you to some of the best and brightest founders, CEOs, executives, business owners, VCs and inspiring leaders who make things happen and inspire others.
Hosted by media and PR veteran and CEO of Mojo Media, Justin Kelly, we chat to leaders on the front line on how to get started, what it takes to build a successful business, how to overcome challenges, and advice for those on a similar journey.
In this episode, Justin speaks with Joel Hardy, CEO of Cymra Life Sciences.
Cymra Life Sciences is an Australian owned licenced cultivator and manufacturer of medical cannabis.
Co-founded by Simon Pettinger and Hardy, Cymra is focused on the development of cannabis medicines for chronic and neuropathic pain. Believing there currently aren’t any good medication options for the long-term treatment of chronic pain, Cymra is focused on developing medical cannabis through tissue culture propagation to deliver a consistent, natural product, free from pests and chemical dependencies.
Tune in below to hear more about Cymra’s plans for the future, what sets it apart from other cannabis companies and how its unique system is able to cultivate greater quantities over traditional propagation methods.